InBio Attending EAACI in 2026
June 12 - June 15
The EAACI Annual Congress returns to Istanbul after 15 years. Back in 2011, Dr. Anna Pomés, Director of Basic Research at InBio, presented a talk on the identification of antibody binding sites on group 1 mite allergens by X-ray crystallography. Major progress has been made since, leading to the identification of human IgE mAb from hybridomas and the mapping of their associated epitopes.
EAACI’s return to Istanbul this year is fitting, as Dr. Pomés is featured in a talk on the rational design of a Der p 2 hypoallergen based on IgE dominant epitopes. Research made real!
InBio will have other presentations covering such diverse topics as a Synthetic Peanut Serum and molecular peanut composites for use in BAT and allergy diagnostics, distinct allergen profiles of peanut materials, and environmental exposure to different dust mite species.
Let’s celebrate progress in the allergen field together at booth H01.
Contact Ross Yarham (Ryarham@inbio.com) if you’d like to setup a meeting.